Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Davis

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Pain|June 21, 2016
A standardized clinical evaluation of phenotypic diversity in diabetic polyneuropathyJoachim Scholz, James P Rathmell, William S David, et al.
Journal of Neurochemistry|December 13, 2006
Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivoIshrut Hussain, Julie Hawkins, David Harrison, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 3, 2008
The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazoneEmma L Akuffo, John B Davis, Steven M Fox, et al.
Journal of Proteome Research|January 13, 2025
Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent InhibitorDarragh P O'Brien, Hannah B L Jones, Yuqi Shi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 30, 2007
Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptorMartin J Gunthorpe, Sara Luis Hannan, Darren Smart, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 30, 2009
A key role for gp130 expressed on peripheral sensory nerves in pathological painManfred Andratsch, Norbert Mair, Cristina E Constantin, et al.
Structure (London, England : 1993)|July 7, 2021
Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomainAleksandra Szykowska, Yu Chen, Thomas B Smith, et al.
Human Molecular Genetics|June 29, 2023
Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson's disease modelsMatthew G Williamson, Marta Madureira, William McGuinness, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2008
Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1Susan M Westaway, Mervyn Thompson, Harshad K Rami, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasmaPaul Cutler, Emma L Akuffo, Wanda M Bodnar, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Pain|June 21, 2016
A standardized clinical evaluation of phenotypic diversity in diabetic polyneuropathyJoachim Scholz, James P Rathmell, William S David, et al.
Journal of Neurochemistry|December 13, 2006
Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivoIshrut Hussain, Julie Hawkins, David Harrison, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 3, 2008
The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazoneEmma L Akuffo, John B Davis, Steven M Fox, et al.
Journal of Proteome Research|January 13, 2025
Structural Dynamics of the Ubiquitin Specific Protease USP30 in Complex with a Cyanopyrrolidine-Containing Covalent InhibitorDarragh P O'Brien, Hannah B L Jones, Yuqi Shi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 30, 2007
Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptorMartin J Gunthorpe, Sara Luis Hannan, Darren Smart, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 30, 2009
A key role for gp130 expressed on peripheral sensory nerves in pathological painManfred Andratsch, Norbert Mair, Cristina E Constantin, et al.
Structure (London, England : 1993)|July 7, 2021
Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomainAleksandra Szykowska, Yu Chen, Thomas B Smith, et al.
Human Molecular Genetics|June 29, 2023
Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson's disease modelsMatthew G Williamson, Marta Madureira, William McGuinness, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2008
Design and synthesis of 6-phenylnicotinamide derivatives as antagonists of TRPV1Susan M Westaway, Mervyn Thompson, Harshad K Rami, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasmaPaul Cutler, Emma L Akuffo, Wanda M Bodnar, et al.
Pageof 6